Roles of reactive oxygen species in hepatocarcinogenesis and drug resistance gene expression in liver cancers

Molecular Carcinogenesis

Volumn 45, Issue 9, 2006, Pages 701-709

  Kuo, M Tien ^a   Savaraj, Niramol ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Animal models; Gene regulation; Multidrug resistance; Signal pathway

Indexed keywords

CARCINOGEN; REACTIVE OXYGEN METABOLITE; STEROID HORMONE; TOXIN;

ALCOHOL CONSUMPTION; CANCER MODEL; CANCER RESEARCH; CANCER RESISTANCE; CANCER SURVIVAL; CHRONIC HEPATITIS; CYTOTOXICITY; DIET; GENE EXPRESSION REGULATION; HEPATITIS B; HEPATITIS C; HUMAN; LIVER BIOPSY; LIVER CANCER; LIVER CARCINOGENESIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MICE; REACTIVE OXYGEN SPECIES;

ANIMALIA;

EID: 33748807185     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20240     Document Type: Review

References (96)

1. Ferlay J, Bray F, Pisani P, Parkin DMJ. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, version 1.0., IARC CancerBase No. 5, Lyon, IARC Press, 2001.
2. Bosch FX, Ribes J, Borràs J. Epidemiology of primary liver cancer. Semin Liver Dis 1999;19:271-285.
3. Carr BI. Hepatocellular carcinoma: Current management and future trends. Gasteroent 2004;127:S218-S214.
4. Bruix J, Boix L, Sala M, Llovet JM. Focus on hepatocellular carcinoma. Cancer Cell 2004;5:215-219.
5. Thorgeirsson SS, Grisham JW. Molecular genesis of human hepatocellular carcinoma. Nature Genet 2002;31:339-346.
6. Inoue M, Sato EF, Nishikawa M, et al. Mitochondrial generation of reactive oxygen species and its role in aerobic life. Curr Med Chem 2003;10:2495-2505.
7. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nature Rev Immunol 2004;4:181-189.
8. Finkel T. Oxidant signals and oxidative stress. Curr Opin Cell Biol 2003;15:247-254.
9. Waris G, Huh K-W, Siddiqui A. Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-κB via oxidative stress. Mol Cell Biol 2001;21:7721-7730.
10. Gong G, Waris G, Tanveer R, Siddiqui A. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB. Proc Natl Acad Sci USA 2001;98:9599-9604.
11. Hagen TM, Huang S, Curnutte J, Fowler P, Martinez V, Wehr CM, Ames BN, Chisari FV. Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. Proc Natl Acad Sci USA 1994;9:12808-12812.
12. Moriya K, Fujie H, Shintani Y, Yotsuyanagi H, Tsutsumi T, Ishibashi K, Matsuura Y, Kimura S, Miyamura T, Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998;4:1065-1067.
13. Moriya K, Nakagawa K, Santa T, et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 2001;61:4365-4370.
14. Gallagher EP, Kunze KL, Stapleton PL, Eaton DL. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4. Toxicol Appl Pharmacol 1996;141:595-606.
15. Shen H-M, Shi C-Y, Shen Y, Ong C-H. Detection of elevated reactive oxygen species levels in cultured rat hepatocytes treated with aflatoxin B1. Free Rad Biol Med 1996;21:134-146.
16. Klohn PC, Massalha H, Neumann HG. A metabolite of carcinogenic 2-acetylaminofluorene, 2-nitrosofluorene, induces redox cycling in mitochondria. Biochim Biophys Acta 1995;1229:363-372.
17. Kuo MT, Liu Z, Wei Y, et al. Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling. Oncogene 2002;21:1945-1954.
18. Luo J, Manning BD, Cantley LC. Targeting the PI3K-AKT pathway in human cancer: Rationale and promise. Cancer Cell 2003;4:257-262.
19. Reddy JK. Peroxisome proliferators and peroxisome proliferators-activated receptor alpha: Biotic and xenobiotic sensing. Am J Pathol 2004;164:2305-2321.
20. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990;347:645-650.
21. Youaawd JA, Badr MS. Agents enhanced hepatocarcinogenicity by peroxisome proliferator-activated receptor alpha agonists. Ageing Res Rev 2005;4:105-118.
22. Reddy JK, Rao MS, Moody DE. Hepatocellular carcinoma in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator. Cancer Res 1976;36:1211-1217.
23. Fan CY, Pan J, Usuda N, Yeldandi AV, Rao MS, Reddy JK. Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-coA oxidase: Implications for peroxisome proliferator-activated receptor a natural ligand metabolism. J Biol Chem 1998;273:5639-15645.
24. Bae YS, Kang SW, Seo MS, Baines IC, Tekle E, Chock PB, Rhee SG. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J Biol Chem 1997;272:217-221.
25. 2 production requires the activation of phosphatidylinositol 3-kinase. J Biol Chem 200;275:10527-10531.
26. Ushio-Fukai M, Alexander RW. Reactive oxygen species as mediators of angiogenesis signaling: Role of NAD(P)H oxidase. Mol Cell Biochem 2004;264:85-97.
27. Mahadev K, Wu X, Zilbering A, Zhu L, Lawrence JT, Goldstein BJ. Hydrogen peroxide generated during cellular insulin stimulation is integral to activation of the distal insulin signaling cascade in 3T3-L1 adipocytes. J Biol Chem 2001; 276:48662-48669.
28. Lo YY, Wong JM, Cruz TF. Reactive oxygen species mediate cytokine activation of c-jun NH2-terminal kinases. J Biol Chem 1996;271:11727-15730.
29. Li WQ, Qureshi HY, Liachini A, Dehnade F, Zafarullah M. Transforming growth factor b1 induction of tissue inhibitor of metalloproteinase 3 in articular chondrocytes is mediated by reactive oxygen species. Free Radic Biol Med 2004;37:196-205.
30. Daou GB, Srivasta AK. Reactive oxygen species mediate endothelin-1-induced activation of Erk1/2, PKB, and Pyk2 signaling, as well as protein synthesis, in vascular smooth muscle cells. Free Red Biol Med 2004;31:208-215.
31. Vafa O, Wade M, Kern S, et al. C-Myc can induce DNA damage, increase reactive oxygen species, and mitigate p53 function: A mechanism for oncogene-induced genetic instability. Molec Cell 2002;9:1031-1044.
32. Factor VM, Kiss A, Woitach JT, Wirth PJ, thorgeirsson SS. Disruption of redox homeostasis in the transforming growth factor-alpha/c-myc transgenic mouse model of accelerated hepatocarcinogenesis. J Biol Chem 1998;273:15846-15853.
33. Factor VM, Laskowska D, Jensen MR, Woitch JT, Popescu NC, Thorgeirsson SS. Vitamin E reduces chromosomal damage and inhibits hepatic tumor formation in a transgenic mouse model. Proc Natl Acad Sci USA 2000;97:2196-2201.
34. Calvisi DF, Ladu S, Hironaka K, Factor VM, Thorgeirsson SS. Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-α transgenic mouse model of livercancer. J Hepatol 2004;41:815-822.
35. Elchuri S, Oberley TD, Oi W, et al. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene 2005;24:367-380.
36. Tao TY, Gitlin JD. Hepatic copper metabolism: Insights from genetic disease. Hepatology 2003;37:1241-1247.
37. Koizumi M, Fujii J, Suzuki K, et al. A marked increase in free copper levels in the plasma and liver of LEC rats: An animal model for Wilson disease and liver cancer. Free Radic Res 1998;28:441-450.
38. Buiakova OI, Xu J, Lutsenko S, et al. Null mutation of the murine ATP7B (Wilson disease) gene results in intracellular copper accumulation and late-onset hepatic nodular transformation. Hum Mol Genet 1999;8:1665-1671.
39. Meng Y, Miyoshi I, Hirabayashi M, et al. Restoration of copper metabolism and rescue of hepatic abnormalities in LEC rats, an animal model of Wilson disease, by expression of human ATP7B gene. Biochim BiophysActa 2004;1690:208-219.
40. Xu Z, Chen L, Leung L, Yen TSB, Lee C, Chan JY. Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. Proc Natl Acad Sci USA 2005;102:4120-4125.
41. Maeda S, Kamata H, Luo J-L, Leffert H, Karin M. IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005;121:977-990.
42. Bailey SM. A review of the role of reactive oxygen and nitrogen species in alcohol-induced mitochondrial dysfunction. Free Rad Res 2003;37:585-596.
43. Wheeler MD. Endotoxin and Kupffer cell activation in alcoholic liver disease. Alcohol Res Health 2003;27:300-306.
44. Wu D, Cederbaum Al. Alcohol, oxidative stress, and free radical damage. Alcohol Res Health 2003;27:277-284.
45. Yamagiwa K, Mizumoto R, Higashi S, et al. Alcohol ingestion enhances hepatocarcinogenesis induced by synthetic estrogen and progestin in the rat. Cancer Detect Prev 1994;18:103-114.
46. Valgimigli M, Valgimigli L, Trere D, et al. Oxidative stress EPR measurement in human liver by radical-probe techynique. Correlation with etiology, histology and cell proliferation. Free Radi Res 2002;36:939-948.
47. Casaril M, Corso F, Bassi A, et al. Decreased activity of scavenger enzymes in human hepatocellular carcinoma, but not in liver metastases. Int J Clin Lab Res 1994;24:94-97.
48. Liaw KY, Lee PH, Wu FC, Tsai JS, Lin-Shiau SY. Zinc, copper, and superoxide dismutase in hepatocellular carcinoma. American J Gastroenterol 1997;92:2260-2263.
49. Jungst C, Cheng B, Gehrke R, et al. Liver failure and liver disease. Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma. Hepatol 2004;39:1663-1672.
50. Xu X-R, Huang J, Xu Z-G, et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci USA 2001;98:150890-150894.
51. Delpuech O, Trabut J-B, Carnot F, Feuillard J, Brechot C, Kremsdorf D. Identification, using cDNA macroarray analysis, of distinct expression profiles associated with pathological and virological features of hepatocellular carcinoma. Oncogene 2002;21:2926-2937.
52. Lee JS, Thorgeirsson SS. Genetic profiling of human hepatocellular carcinoma. Semin Liver Disease 2005;25:125-132.
53. Lee J-S, Chu I-S, Mikaelyan A, et al. Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nat. Genet. 2004;36:1306-1311.
54. Cerutti PA. Oxy-radicals and cancer. Lancet 1994;344:862-863.
55. Dreher D, Junod AF. Role of oxygen free radicals in cancer development. Eur J Cancer 1996;32:30-38.
56. Klaunig JE, Kamendulis LM. The roles of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 2004;44:239-267.
57. Demple B, Harrison L. Repair of oxidative damage to DNA. Annu Rev Biochem 1994;63:915-948.
58. Kuo MT, Sen S, Hittelman WN, Hsu TC. Chromosomal fragile sites and DNA amplification in drug-resistant cells. Biochem Pharmacol 1998;156:7-13.
59. Ljungman M. Activation of DNA damage signaling. Mutat Res 2005;577:203-216.
60. Janero DR. Malondialdehyde and thiobarbituric acid reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injure. Free Rad Biol Med 1990;9:515-540.
61. Saitoh M, Nishitoh H, Fujii M, et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 1998;17:2596-2606.
62. Kamata H, Honda S-i, Maeda S, Chang L, Hirata H, Karin M. Reactive oxygen species promote TNFα-induced death and sustain JNK activation by inhibiting MAP kinase phosphatases. Cell 2005;120:649-661.
63. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarash K, Yamamoto M. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev 1999;13:76-86.
64. Wakabayashi N, Dinkova-Kostova AT, Holtzclaw WD, et al. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc Natl Acad Sci USA 2004;101:2040-2045.
65. Kabe Y, Ando K, Hirao S, Yoshida M, Handa H. Redox regulation of NF-kB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxidants Redox Signal 2005;7:395-403.
66. Jenssen-Heininger YM, Poynter ME, Bauerle PA. Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. Free Rad Biol Med 2000;28:1217-1327.
67. Greten FR, Eckmann L, Greten TF, et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004;118:285-296.
68. Pikarsky E, Porat RM, Stein I, et al. NF-κB functions as a tumor promoter in imflammation-associated cancer. Nature 2004; 431:461-466.
69. Liu P, Kimmoun E, Legrand A, et al. Activation of NF-kappaB, AP-1 and Stat transcriptions is a frequent and early event in human carcinomas. J Hepatol 2002;37:63-71.
70. Allen RG, Tresini M. Oxidative stress and gene regulation. Free Rad Biol Med 2000;28:463-499.
71. Bouwman P, Philipsen S. Regulation of the activity of Sp1-related transcription factors. Mol Cell Endocrinol 2002;195:27-38.
72. Vivanco I, Sawyers SL. Thephosphatidylinositol 3-kinase-AKT pathway in human cancer. Nature Rev Cancer 2002;2:489-501.
73. Street A, Macdonald A, McCormick C, Harris M. Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription. J Virol 2005;79:5006-5016.
74. Yao YJ, Ping XL, Zhang H, et al. PTEN/MMAC1 mutations in hepatocellular carcinomas. Oncogene 1999;18:3181-3185.
75. Hu TH, Huang CC, Lin PR, et al. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma. Cancer 2003;97:1929-1940.
76. Horie Y, Suzuki A, Kataoka E, et al. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J Clin Invest 2004;113:1774-1783.
77. Miller JR, Hocking AM, Brown JD, Moon RT. Mechanism and function of signal transduction by the Wnt/b-catenin and Wnt/Ca2+ pathways. Oncogene 1999;18:7860-7872.
78. Essers MAG, de Vries-Smits LMM, Barker N, Polderman PE, Burgering BMT, Korswagen HC. Functional interaction between β-catenin and FOXO in oxidative stress signaling. Science 2005;208:1181-1184.
79. Brunet A, Sweeney LB, Sturgill JF, et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004;303:2011-2015.
80. Kos GL, Dansen TB, Polderman PE, et al. Forkhead transcription factor FOXO3 protects quiescent cells from oxidatgive stress. Nature 2002;419:316-321.
81. Taniquchi K, Roberts LR, Aderca IN, et al. Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene 2002;21:4863-4871.
82. de la Coste A, Romagnolo B, Billuart P, et al. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 1998;95:8847-8851.
83. Maulik N. Redox signaling of angiogenesis. Antioxidants Redox Signal 2002;4:805-815.
84. Ushio-Fukai M, Alexander RW, Reactive oxygen species as mediators of angiogenesis signaling: Role of NAD(P)H oxidase. Mol Cell Biochem 2004;264:85-97.
85. Kuo MT. Expression of multidrug-resistance (P-glycoprotein) genes in liver cancers: A molecular example of the convergence theory of hepatocarcinogenesis? Molec Carcinog 1993;7:73-75.
86. Teeter LD, Becker FF, Chisari FV, Li DJ, Kuo MT. Overexpression of the multi-drug-resistance gene mdr3 in spontaneous and chemically induced mouse hepatocellular carcinomas. Molec Cell Biol 1990;10:5728-5735.
87. Teeter LD, Estes M, Chan JY, et al. Activation of distinct multidrug-resistance (P-glycoprotein) genes during rat liver regeneration and hepatocarcinogenesis. Mol Carcinog 1993;8:67-73.
88. Deng L, Lin-Lee YC, Claret FX, Kuo MT. 2-acetylaminofluorene up-regulates rat mdrlb expression through generating reactive oxygen species that activate NF-kappa B pathway. J Biol Chem 2001;276:413-420.
89. Lin-Lee Y-C, Tatebe S, Savaraj N, Ishikawa T, Kuo MT. Differential sensitivities of MRP gene family and gammaglutamylcysteine synthetase to prooxidants in human colorectal carcinoma cell lines with different p53 status. Biochem Pharmacol 2001;61:555-563.
90. Zollner G, Wagner M, Ficklert P, et al. Hepatobiliary transporter expression in human hepatocellular carcinoma. Liver Int 2005;25:367-379.
91. Yamane Y, Furuichi M, Song R, et al. Expression of multidrug resistance protein/GS-X pump and gamma-glutamylcysteine synthetase genes is regulated by oxidative stress. J Biol Chem 1998;273:31075-31085.
92. Kuo MT, Bao JJ, Curley SA, Ikeguchi M, Johnston DA, Ishikawa T. Frequent coordinated overexpression of the MRP/GS-X pump and gamma-glutamylcysteine synthetase genes in human colorectal cancers. Cancer Res 1996;56:3642-3644.
93. Sato K, Kitahara A, Soma Y, Inaba Y, Hatayama I, Sato K. Purification induction, and distribution of placental glutathione transferase: A new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc Natl Acad Sci USA 1985;82:3964-3968.
94. Sugioka Y, Kano T, Okuda A, Sakai M, Kitagawa T, Maramatsu M. Changes in polypeptide pattern of rat liver cells during chemical hepatocarcinogenesis. Cancer Res 1985;45:365-378.
95. Nguyen T, Yang CS, Pickett CB. The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress. Free Radic Biol Med 2004;37:433-441.
96. Song I-S, Tatebe S, Dai W, Kuo MT. Delayed mechanism for induction of γ-glutamylcysteine synthetase heavy subunit mRNA stability by oxidative stress involving p38 mitogen-activated protein kinase signaling. J Biol Chem 2005;280:28230-28240.